Effectiveness of an Intervention Combining Adapted Physical Activity and Therapeutic Education in Patients With Chronic Symptoms Attributed to Lyme Borreliosis. (LyMouv')

Effectiveness of an Intervention Combining Adapted Physical Activity and Therapeutic Education in Patients With Chronic Symptoms Attributed to Lyme Borreliosis. Multicenter, Controlled, Randomized Pilot Study

Lyme borreliosis, commonly known as Lyme disease, has been clinically described for more than a century, but has been officially recognized for 40 years, with the detection of the Borrelia bacterium by W. Burgdorfer, in ticks of the Ixodes ricinus complex, identified a few years before.

Study Overview

Detailed Description

Apart from the early localized presentation, with a well established treatment, Lyme borreliosis is a complex infection. Indeed, its presentation can be late and very polymorphic, which can evoke functional somatic disorders and make its management difficult. In 2016, the French Ministry of Health decided to launch a national plan to fight Lyme borreliosis. One of the objectives of this national plan was to improve management based on a specific multidisciplinary care pathway.

Study Type

Interventional

Enrollment (Estimated)

62

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Clermont-Ferrand, France, 63000
        • Not yet recruiting
        • CHU Clermont-Ferrand
        • Principal Investigator:
          • Léo SAUVAT, MD
      • Saint Etienne, France, 42055
        • Recruiting
        • CHU Saint Etienne
        • Sub-Investigator:
          • BOTELHO-NEVERS Élisabeth, PhD
        • Sub-Investigator:
          • CAZORLA Céline, MD
        • Principal Investigator:
          • David HUPIN, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patient referred to the reference center for tick-borne diseases by his attending physician
  • Duration of symptoms >6 months
  • At the end of the initial assessment, the diagnosis of functional somatic disorders is retained after consensus between the physicians
  • Patient practicing less than 150 minutes of regular physical activity per week (WHO recommendations)

Exclusion Criteria:

  • Patients with cardiac or respiratory pathologies that contraindicate the practice of physical activity physical activity
  • Important comorbidities contraindicating the practice of physical activity: associated cardiac pathologies associated cardiac pathologies (severe rhythm disorders such as rapid atrial fibrillation), respiratory pathologies respiratory pathologies (obstructive or severe restrictive respiratory insufficiency), disabling joint pathologies joint pathologies (gonarthrosis or coxarthrosis limiting training on a treadmill or on a high-intensity bicycle). intensity cycling).
  • Patients under guardianship or curatorship

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Lyme Borreliosis with physical activity program
Referral of the patient to the sport-health center of his department by the investigating physician (in connection with the attending physician for the prescription of Adaptive Physical Activity): for 24 sessions of APA for 3 months at a rate of 2 sessions/week at the sport and health center + 9 sessions of Therapeutic Patient Education in telecare
24 face-to-face APA sessions at the sport and health center for 3 months at a rate of 2 sessions per week near his home and 9 therapeutic patient education workshops for 3 months at a rate of 3 workshops per month (telecare).
Other: Lyme Borreliosis patients with physical activity at home
routine clinical practice : encouragement by the attending physician to modify lifestyle habits with advice on resuming regular physical activity independently and combating sedentariness. At home, in autonomy for 3 months.
Advice and recommendations of physical activity at home (= current clinical practice in autonomy for 3 months).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Average level of moderate to vigorous physical activity (PA) - MET-h/week
Time Frame: 1 year after implementation of the PA program

MET = metabolic equivalent

This is measured with actimetry (Actigraph GT3x, Pensacola, Florida, USA).

1 year after implementation of the PA program

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
average level of sedentary lifestyle (h/day)
Time Frame: at Month 3, Month 6 and Month 12 after implementation of the PA program

This is measured with actimetry (Actigraph GT3x, Pensacola, Florida, USA).

The average sedentary time measured in industrialized countries is about 4 hours per day (excluding time spent sitting at work and in transport)

at Month 3, Month 6 and Month 12 after implementation of the PA program
Average level of moderate to vigorous physical activity (PA) - MET-h/week
Time Frame: at Month 3, Month 6 and Month 12 after implementation of the PA program
This measured with Adult Physical Activity Questionnaire (APAQ) Score from 0 to 21 points, 0 = no difficulty, and 21= major difficulties.
at Month 3, Month 6 and Month 12 after implementation of the PA program
Average level of sedentary lifestyle (h/day)
Time Frame: at Month 3, Month 6 and Month 12 after implementation of the PA program
This measured with Adult Physical Activity Questionnaire (APAQ) Score from 0 to 21 points, 0 = no difficulty, and 21= major difficulties.
at Month 3, Month 6 and Month 12 after implementation of the PA program
VO2max (in ml/min/kg)
Time Frame: at Month 3, Month 6 and Month 12 after implementation of the PA program
This physical ability is measured with a cardiorespiratory test on a cycloergometer
at Month 3, Month 6 and Month 12 after implementation of the PA program
Biceps muscular strength (kg)
Time Frame: at Month 3, Month 6 and Month 12 after implementation of the PA program
Muscular strength will be assessed by biceps muscle strength (in kilograms) on the Handgrip (JAMAR Hand Dynamometer, UK)
at Month 3, Month 6 and Month 12 after implementation of the PA program
Patient Global Impression of Change (PGIC)
Time Frame: at Month 3, Month 6 and Month 12 after implementation of the PA program
Health status will be assessed by the Patient Global Impression of Change (PGIC) and measured on a 7-point Likert scale, rated from 1 for "much worse" to 7 for "much better".
at Month 3, Month 6 and Month 12 after implementation of the PA program
Hospital Anxiety and Depression Scale (HADS)
Time Frame: at Month 3, Month 6 and Month 12 after implementation of the PA program
Psychological distress will be assessed using the Hospital Anxiety and Depression Scale (HADS) The HADS scale has 14 items scored from 0 to 3. 7 questions concern anxiety and 7 others the depressive dimension, which makes it possible to obtain two scores (maximum score for each score = 21). A score greater than or equal to 11 means that the anxiety or depression is anxiety or depression is certain.
at Month 3, Month 6 and Month 12 after implementation of the PA program
Number of patients involved in the intervention
Time Frame: at Month 6 after implementation of the PA program
Assessment of adherence as measured by the number of patients involved in the intervention
at Month 6 after implementation of the PA program
medico-economic impact of the care organization
Time Frame: at Month 12 after implementation of the PA program
Average cost saved per 100 patients treated in the "physical activity program group" compared to the "control group"
at Month 12 after implementation of the PA program

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: David HUPIN, MD, CHU de Saint Etienne

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 14, 2023

Primary Completion (Estimated)

December 1, 2024

Study Completion (Estimated)

December 1, 2025

Study Registration Dates

First Submitted

November 8, 2022

First Submitted That Met QC Criteria

November 29, 2022

First Posted (Actual)

December 7, 2022

Study Record Updates

Last Update Posted (Actual)

October 4, 2023

Last Update Submitted That Met QC Criteria

October 3, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Physical Activity

Clinical Trials on physical activity program

3
Subscribe